학술논문

Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer – The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)
Document Type
Article
Source
In European Journal of Cancer September 2016 64:12-21
Subject
Language
ISSN
0959-8049